The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Masaki Shiota
Honoraria - Astellas Pharma; AstraZeneca; Bayer Yakuhin; Chugai Pharma; Janssen; Sanofi; Takeda
Research Funding - Astellas Pharma
 
Maki Fujiwara
No Relationships to Disclose
 
Takayuki Sumiyoshi
No Relationships to Disclose
 
Hideki Enokida
No Relationships to Disclose
 
Tomomi Kamba
Honoraria - MSD; Takeda
 
Tsukasa Igawa
Honoraria - Bayer Yakuhin
 
Naoya Masumori
Honoraria - Bayer Yakuhin
 
Hirotsugu Uemura
No Relationships to Disclose
 
Toshiyuki Kamoto
Speakers' Bureau - Janssen; Sanofi
Research Funding - AstraZeneca (Inst); Bayer Schering Pharma (Inst); Janssen (Inst); MSD (Inst)
 
Katsuyoshi Higashijima
No Relationships to Disclose
 
Kensuke Mitsunari
No Relationships to Disclose
 
Hiroji Uemura
Honoraria - Bayer Yakuhin; Janssen Oncology; Novartis
Consulting or Advisory Role - AstraZeneca; Bayer Yakuhin; Novartis; Pfizer
 
Takashi Kobayashi
Honoraria - Astellas Pharma; Bayer; Janssen; MSD
Consulting or Advisory Role - Astellas Pharma; Janssen
Speakers' Bureau - Astellas Pharma; Janssen
Research Funding - Astellas Pharma; AstraZeneca; Bayer; Chugai Pharma
 
Shusuke Akamatsu
Honoraria - Astellas Pharma; AstraZeneca; Bayer Yakuhin; Janssen; Sanofi; Takeda
Research Funding - Tosoh Corporation
 
Shoji Tokunaga
No Relationships to Disclose
 
Masatoshi Eto
Consulting or Advisory Role - Boston Scientific; Chugai Pharma; Eisai; Ferring; Intuitive Surgical; Merck; MSD; Novartis; Pfizer; Takeda
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Janssen; Merck; MSD; ONO PHARMACEUTICAL; Pfizer; Takeda
Research Funding - MSD